News | April 01, 2025
Shin-Etsu Chemical to invest in pharmaceutical cellulose business
L-HPC was independently developed by Shin-Etsu Chemical as a disintegrant for tablets
L-HPC was independently developed by Shin-Etsu Chemical as a disintegrant for tablets
The amalgamation is expected to create a future-ready, diversified CDMO platform with a technology-led focus across three high-growth verticals-Antibody Drug Conjugates
The inspection has concluded with four observations
Alembic Pharmaceuticals Ltd. and Amlan International sign exclusive strategic commercial agreement to make poultry health innovations accessible to Indian farmers and integrators
Alembic Pharmaceuticals successfully completes USFDA inspection for API-III facility
The products will be manufactured in Goa India and marketed & distributed in Australian markets
The inspection, conducted from March 17 to March 21, 2025, concluded with one observation in Form 483
PCC has secured the commercialization rights for the EU, UK, and Norway and will be responsible for distributing Neoatricon in these regions
Apitoria Pharma’s API manufacturing facility classified as VAI by USFDA
Talicia is also approved and launched in the UAE and additional countries may accept UK MHRA approvals as a reference for their own marketing approval processes
Subscribe To Our Newsletter & Stay Updated
